Open-house rebate agreement for Eltrombopag

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Sep 05, 2026 · 8 days left·Open·Supplies·Framework

Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Eltrombopag, ATC B02BX05

62/100

Opportunity Score

Needs reviewMedium complexity

SuppliesFrameworkOpen

Why this score?

Opportunity

62 / 100

Complexity

48 / 100

Risk factors

Submission is only valid if the chosen format requirements are met: handwritten paper originals in duplicate or electro...

Participation is restricted to pharmaceutical companies, and suitability must be demonstrated by a signed declaration o...

Submission deadline in 8 days

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Overview

Moderate opportunity

Key Facts

Framework procurement
Supplies contract
1 lot
Duration until Oct 2026
Non-exclusive rebate agreements for the active substance Eltrombopag (ATC B02BX05).
Supply contract for pharmaceutical products.

Show full summary

This is an open-house pharmaceutical supply arrangement for Eltrombopag (ATC B02BX05) offered by AOK Bayern to all interested pharmaceutical companies that meet the stated eligibility requirement. It is not a competitive award procedure in the usual sense: no selection among bidders, identical non-negotiable contract terms, and no explicit award criteria. Contracting is possible throughout the term, with the latest contract conclusion date stated as 2026-09-05. Submission is possible electronically with a qualified electronic signature via DTVP or in paper form in duplicate originals.

Risks

Submission is only valid if the chosen format requirements are met: handwritten paper originals in duplicate or electro...

Participation is restricted to pharmaceutical companies, and suitability must be demonstrated by a signed declaration o...

Submission deadline in 8 days

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

The contract and the annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be completed and signed.

Eligibility

Only pharmaceutical companies are eligible as potential contract partners.

Administrative

A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.

Buyer

Name

AOK Bayern - Die Gesundheitskasse

Location

München, DEU

[email protected]

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Eltrombopag

Single lot for non-exclusive open-house rebate agreements for the medicinal product Eltrombopag, ATC B02BX05. Scope is pharmaceutical supplies in Germany (place of performance: DEU, DE212). The lot is described as an open-house model with identical, non-individually negotiated contract terms.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Oct 2024 - Oct 2026

Procurement Details

Publication date: 16 Sep 2024
Languages: German

Reference metadata

Legal basis: 32014L0024

Reference IDs

Tender ID: 558406-2024

Documents (2)

Procurement document 1 Submission portal 1

Similar tenders

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3